Dechra announces U.S. launch of Solovecin™ (cefovecin sodium), an in-clinic antibiotic solution for skin infections in dogs and cats
Dechra, the global leader in veterinary specialty care, is proud to announce the U.S. launch of Solovecin™ (cefovecin sodium), a long-acting injectable antibiotic for the treatment of skin infections in dogs and cats — the top reason veterinarians prescribe antibiotics.1 With skin infections affecting 10-15% of the canine population and up to 20% of the feline population, Solovecin gives veterinarians an affordable tool to extend quality care to more patients, including cats and larger dogs.
Solovecin is now available for order from all major veterinary distributors.
Poor compliance leads to more than just poor outcomes
Compliance with medication administration isn’t just a challenge; it’s a risk. Inconsistent antibiotic administration contributes to treatment failure, more expense and time at the veterinary clinic, diminished trust in care, and ultimately, degradation of the special bond people share with their pets.
“When it comes to antibiotics, successful treatment is highly dependent on the drug being given correctly by the pet owner. Missed dosages, abbreviated treatment courses, and inaccurate reporting by the pet owner are common roadblocks," said Darin Dell, DVM, DACVD. "With Solovecin, the patient is getting their full course of treatment in one simple injection at the veterinary clinic, eliminating compliance concerns and supporting better health outcomes."
A smart, practical portfolio for real-world challenges
Skin conditions consistently rank as one of the top reasons for veterinary visits. Dechra’s comprehensive antibiotic portfolio for dogs and cats gives veterinarians the freedom and flexibility to find the right solution for their patients’ needs.
“Solovecin is an exciting addition to our growing antibiotic portfolio and, more importantly, showcases Dechra’s ongoing commitment to providing pragmatic solutions to veterinary healthcare teams,” said Laura Olsen, President, North America and Chief Marketing Officer, Dechra. “Solovecin reflects Dechra’s commitment to preserving the power of the human-animal bond and supporting veterinarians with in-clinic solutions.”
In addition to Solovecin, Dechra’s portfolio includes:
- Clavacillin® (amoxicillin and clavulanate potassium tablets), USP Veterinary Tablets
- Clavacillin® (amoxicillin and clavulanate potassium for oral suspension), USP Drops
- Cefpoderm® (cefpodoxime proxetil tablets)
- Marboquin® Chewable Tablets (marbofloxacin)
- Enroquin® (enrofloxacin) Flavored Tablets
- Enroquin® (enrofloxacin) Antibacterial Injectable Solution 2.27%
About Solovecin
Cefovecin sodium is a semi-synthetic broad-spectrum antibacterial agent from the cephalosporin class. Each mL of Solovecin reconstituted lyophile contains cefovecin sodium equivalent to 80.0 mg cefovecin, methylparaben 1.8 mg (preservative), propylparaben 0.2 mg (preservative), sodium citrate dihydrate 5.8 mg, and citric acid monohydrate 0.1 mg, sodium hydroxide or hydrochloric acid as required to adjust pH.
Dogs:
Solovecin is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Cats:
Solovecin is indicated for the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
Important Safety Information
As with all drugs, side effects may occur. People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to Solovecin. Do not use in animals with a history of allergic reactions to penicillins or cephalosporins. Side effects for both dogs and cats include vomiting, diarrhea, decreased appetite/anorexia, and lethargy. Refer to the prescribing information for complete details or visit www.dechra-us.com.
About Dechra
Dechra is a global specialist in veterinary pharmaceuticals and related products. The company focuses on the development, manufacturing, and marketing of high-quality veterinary products to support animal health and welfare worldwide.
Source: www.dechra-us.com
Comments
Tag
Related Articles
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment